IGCIGC Pharma, Inc.同业对比
IGC Pharma, Inc. 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IGC本股 | $25M#10 | — | 4.1x#9 | 19.7x#6 | -5.5%#6 | 45.2%#5 | -585.8%#4 | -116.4%#6 | -123.1%#5 | 3#4 | -28.1%#6 | — |
| MIRA | $29M#3 | — | 3.1x#7 | — | — | -33.0%#13 | — | -111.7%#5 | — | — | -56.7%#9 | — |
| ABVC | $28M#4 | — | 2.6x#6 | 94.9x#9 | 48.0%#4 | -61.3%#14 | -2416.0%#7 | -73.4%#3 | -65.9%#3 | — | -66.1%#13 | — |
| KYNB | $27M#5 | 0.2x#3 | — | 4.2x#3 | -78.3%#9 | 485.6%#1 | -712.7%#6 | — | — | — | -3.2%#4 | — |
| ACTU | $27M#6 | — | 7.2x#12 | — | — | 18.5%#7 | — | -587.4%#12 | — | — | -83.8%#15 | — |
| SER | $33M#2 | — | — | 250.3x#10 | 132.1%#2 | -72.2%#16 | -18478.5%#10 | — | — | 5#1 | -58.2%#11 | — |
| CRVO | $26M#8 | 0.0x#1 | 2.5x#5 | 6.5x#4 | -58.9%#7 | -65.6%#15 | -706.2%#5 | -254.1%#10 | -1038.7%#7 | — | -69.7%#14 | — |
| ATNM | $26M#9 | — | 11.1x#13 | 285.1x#11 | — | 11.4%#9 | -40274.4%#12 | -1470.8%#13 | — | — | -50.6%#8 | — |
| HCWB | $25M#11 | — | 4.3x#10 | 453.2x#12 | -97.9%#10 | 73.5%#3 | -24270.7%#11 | -138.1%#7 | -118.5%#4 | 3#4 | -85.2%#16 | — |
| BRNS | $25M#12 | — | 0.4x#1 | — | -100.0%#11 | -8.8%#11 | — | -100.0%#4 | -10079.3%#8 | — | -57.1%#10 | — |
| AYTU | $24M#13 | — | 0.7x#2 | 0.4x#1 | 1.8%#5 | 14.4%#8 | -11.8%#1 | -38.6%#2 | -41.4%#2 | 4#3 | -14.3%#5 | — |
| TXMD | $24M#14 | 102.3x#4 | 0.9x#4 | 7.8x#5 | 71.6%#3 | 73.9%#2 | -145.3%#2 | -2.1%#1 | -3.8%#1 | 5#1 | 71.8%#1 | — |
| BTAI | $27M#7 | — | — | 41.4x#7 | -71.7%#8 | -17.3%#12 | -7860.0%#9 | — | — | — | -65.8%#12 | — |
| RNTX | $66M#1 | — | 5.7x#11 | — | — | 20.7%#6 | — | -430.5%#11 | — | — | -32.6%#7 | — |
| NXTC | $21M#15 | — | 0.8x#3 | 0.9x#2 | 252.6%#1 | -0.3%#10 | -257.5%#3 | -209.0%#9 | -406.1%#6 | — | 15.1%#3 | — |
| ALLR | $21M#16 | 0.0x#2 | 3.1x#8 | 66.1x#8 | — | 54.2%#4 | -3939.1%#8 | -162.3%#8 | — | — | 31.7%#2 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-08-05。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议